PT697405E - Derivados substituidos de quinolina processos para a sua producao e sua utilizacao - Google Patents

Derivados substituidos de quinolina processos para a sua producao e sua utilizacao

Info

Publication number
PT697405E
PT697405E PT95112585T PT95112585T PT697405E PT 697405 E PT697405 E PT 697405E PT 95112585 T PT95112585 T PT 95112585T PT 95112585 T PT95112585 T PT 95112585T PT 697405 E PT697405 E PT 697405E
Authority
PT
Portugal
Prior art keywords
alkyl
utilization
production
quinoline derivatives
cooh
Prior art date
Application number
PT95112585T
Other languages
English (en)
Inventor
Irvin Winkler
Rosner Dr Manfred
Riess Dr Gunther
Kirsch Dr Reinhard
Kleim Dr Jorg-Peter
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of PT697405E publication Critical patent/PT697405E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/24Oxygen atoms attached in position 8
    • C07D215/26Alcohols; Ethers thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/36Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/20Spiro-condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PT95112585T 1994-08-16 1995-08-10 Derivados substituidos de quinolina processos para a sua producao e sua utilizacao PT697405E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4428932A DE4428932A1 (de) 1994-08-16 1994-08-16 Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
PT697405E true PT697405E (pt) 2002-12-31

Family

ID=6525747

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95112585T PT697405E (pt) 1994-08-16 1995-08-10 Derivados substituidos de quinolina processos para a sua producao e sua utilizacao

Country Status (24)

Country Link
US (1) US5798365A (pt)
EP (1) EP0697405B1 (pt)
JP (1) JP3860618B2 (pt)
KR (1) KR960007567A (pt)
CN (1) CN1123275A (pt)
AT (1) ATE222239T1 (pt)
AU (1) AU710238B2 (pt)
CA (1) CA2156128A1 (pt)
CZ (1) CZ209095A3 (pt)
DE (2) DE4428932A1 (pt)
DK (1) DK0697405T3 (pt)
ES (1) ES2179857T3 (pt)
FI (1) FI953841A (pt)
HR (1) HRP950446A2 (pt)
HU (1) HUT73133A (pt)
IL (1) IL114937A0 (pt)
NO (1) NO306296B1 (pt)
NZ (1) NZ272730A (pt)
PL (1) PL310030A1 (pt)
PT (1) PT697405E (pt)
SI (1) SI9500260A (pt)
SK (1) SK100695A3 (pt)
TW (1) TW407151B (pt)
ZA (1) ZA956798B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7397363B2 (en) * 1993-06-08 2008-07-08 Raymond Anthony Joao Control and/or monitoring apparatus and method
US6658833B2 (en) * 2000-11-09 2003-12-09 Bestrake, Llc Collector and separator apparatus for lawn and garden
AU2005316739A1 (en) * 2004-12-13 2006-06-22 Galileo Pharmaceuticals, Inc. Spiro derivatives as lipoxygenase inhibitors
DE102008022221A1 (de) * 2008-05-06 2009-11-12 Universität des Saarlandes Inhibitoren der humanen Aldosteronsynthase CYP11B2
MA34397B1 (fr) 2010-07-02 2013-07-03 Gilead Sciences Inc Dérivés d'acide napht-2-ylacétique dans le traitement du sida
PE20130525A1 (es) * 2010-07-02 2013-05-05 Gilead Sciences Inc Derivados de acido 2 quinolinil acetico como compuestos antivirales frente a vih
CA2833377C (en) 2011-04-21 2019-02-12 Gilead Sciences, Inc. Benzothiazole compounds and their pharmaceutical use
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
US9376392B2 (en) 2012-01-04 2016-06-28 Gilead Sciences, Inc. 2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
PE20141558A1 (es) 2012-04-20 2014-11-06 Gilead Sciences Inc Derivados de acido benzotiazol-6-il acetico y su uso para tratar una infeccion por vih

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1580492A (en) * 1991-03-14 1992-10-21 Upjohn Company, The Reissert compounds as anti-hiv agents
DE4142322A1 (de) * 1991-12-20 1993-07-01 Hoechst Ag Chinoxaline, verfahren zu ihrer herstellung und ihreverwendung
TW304945B (pt) * 1992-06-27 1997-05-11 Hoechst Ag

Also Published As

Publication number Publication date
ES2179857T3 (es) 2003-02-01
NZ272730A (en) 1998-01-26
TW407151B (en) 2000-10-01
DE4428932A1 (de) 1996-02-22
CA2156128A1 (en) 1996-02-17
CN1123275A (zh) 1996-05-29
HUT73133A (en) 1996-06-28
US5798365A (en) 1998-08-25
SK100695A3 (en) 1996-06-05
NO953204D0 (no) 1995-08-15
KR960007567A (ko) 1996-03-22
HU9502403D0 (en) 1995-10-30
JPH0859621A (ja) 1996-03-05
CZ209095A3 (en) 1996-03-13
AU2853195A (en) 1996-02-29
EP0697405A1 (de) 1996-02-21
AU710238B2 (en) 1999-09-16
SI9500260A (en) 1996-02-29
ZA956798B (en) 1996-03-19
EP0697405B1 (de) 2002-08-14
HRP950446A2 (en) 1997-08-31
JP3860618B2 (ja) 2006-12-20
DK0697405T3 (da) 2002-12-16
NO306296B1 (no) 1999-10-18
PL310030A1 (en) 1996-02-19
NO953204L (no) 1996-02-19
DE59510318D1 (de) 2002-09-19
FI953841A (fi) 1996-02-17
IL114937A0 (en) 1995-12-08
ATE222239T1 (de) 2002-08-15
FI953841A0 (fi) 1995-08-14

Similar Documents

Publication Publication Date Title
PT697405E (pt) Derivados substituidos de quinolina processos para a sua producao e sua utilizacao
BR9609950A (pt) Uso de derivados de adamantano para o tratamento de doenças do ouvido interno
DE69023588D1 (de) Disubstituierte Acetylene mit einer Heteroarylgruppe und mit einer 2-substituierten Chromanyl-, Thiochromanyl- oder 1,2,3,4-Tetrahydrochinolinylgruppe mit retinoidähnlicher Wirkung.
ES8604927A1 (es) Procedimiento para la preparacion de nuevos compuestos fluoroalcoxilicos
AU6109194A (en) Ortho-substituted 2-methoxyiminophenylacetic acid methylamides
ES8203364A1 (es) Un procedimiento para la preparacion de un derivado de ani- lina.
ES2042807T3 (es) 6-fenil-dihidro-3(2h)-piridazinonas, procedimiento para su preparacion, y medicamentos que contienen estos compuestos.
ES2173087T3 (es) Compuesto de azetidinona y procedimiento para su preparacion.
ES8606337A1 (es) Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht.
ATE219484T1 (de) 4-indolylpiperazinyl-derivate
PT1165485E (pt) Processo para a preparacao de produtos intermediarios pesticidas
BR8406575A (pt) Compostos,processo para sua preparacao,sua aplicacao,herbicidas e agentes reguladores de crescimento,e processo para combater plantas indesejadas
ES2146661T3 (es) Nuevos derivados de cefem.
BR9608781A (pt) Composto processo para sua preparação mistura adequada para o controle de pestes fúngidas e de animais processo de controle de pestes fúngicas e animais e uso dos compostos
ES2097469T3 (es) Utilizacion de un agente para aumentar la velocidad de endurecimiento de los cementos, los morteros y los hormigones, aunque manteniendo su manejabilidad.
PT784973E (pt) Derivados de quinoxalina para o tratamento de zumbido nos ouvidos
IE45646L (en) Substituted 2, 3-alkylenedioxybenzamides
AU6828898A (en) Phenylketiminooxybenzyl compounds, method for the production and use thereof
MX9605679A (es) 3-fenilpirazoles sustituidos.
AU606701B2 (en) Antipsychotic compositions containing dioxopiperidine derivatives
DE68902626D1 (de) Dioxopiperidinderivate enthaltende arzneimittel zur verbesserung des gedaechtnisses.